Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ACLY | P53396 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ODC1 | P11926 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27299294 | 0.97 | THRB (0.40) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL1314472 | 0.83 | THRB (0.50) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL1132953 | 0.81 | THRB (0.54) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL5494043 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL5496340 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL5485668 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL5486150 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL5487374 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL981794 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 | |
| SCHEMBL198881 | 0.79 | THRB (0.58) | THRBACLYTSHRKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559448-B2 | Methods for functionalization hydrocarbons | UNIVERSITY OF VIRGINA PATENT FOUNDATION (US) | 2026-02-24 | — | — | US | claimed |
| WO-2025106778-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | LUTUM TECHNOLOGY, LLC (US) | 2025-05-22 | — | — | WO | claimed |
| WO-2025061960-A1 | PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS | CHIRON AS (NO) | 2025-03-27 | — | — | WO | claimed |
| EP-4527829-A1 | PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS | Chiron AS (NO) | 2025-03-26 | — | — | EP | claimed |
| US-20220185748-A1 | METHODS FOR FUNCTIONALIZATION HYDROCARBONS | UNIVERSITY OF VIRGINIA | 2022-06-16 | — | — | US | claimed |
| WO-2020186195-A1 | METHODS FOR FUNCTIONALIZATION HYDROCARBONS | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2020-09-17 | — | — | WO | claimed |
| US-10450259-B2 | Compositions and methods for hydrocarbon functionalization | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2019-10-22 | — | — | US | claimed |
| US-20170152207-A1 | COMPOSITIONS AND METHODS FOR HYDROCARBON FUNCTIONALIZATION | UNITED STATES DEPARTMENT OF ENERGY | 2017-06-01 | — | — | US | claimed |
| US-9604890-B2 | Compositions and methods for hydrocarbon functionalization | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2017-03-28 | — | — | US | claimed |
| US-20160145188-A1 | COMPOSITIONS AND METHODS FOR HYDROCARBON FUNCTIONALIZATION | UNITED STATES DEPARTMENT OF ENERGY | 2016-05-26 | — | — | US | claimed |
| WO-2014210270-A1 | COMPOSITIONS AND METHODS FOR HYDROCARBON FUNCTIONALIZATION | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2014-12-31 | — | — | WO | claimed |
| EP-0804735-A4 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | HOPE CITY (US) | 1999-12-22 | — | — | EP | claimed |
| US-5807748-A | N-terminal protein sequencing reagents and methods which form amino acid detectable by a variety of techniques | CITY OF HOPE (US) | 1998-09-15 | — | — | US | claimed |
| EP-0804735-A1 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | CITY OF HOPE (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1996002003-A1 | N-TERMINAL PROTEIN SEQUENCING REAGENTS AND METHODS WHICH FORM AMINO ACID DERIVATIVES | CITY OF HOPE (US) | 1996-01-25 | — | — | WO | claimed |
| US-12628589-B2 | Etching method using oxygen-containing hydrofluorocarbon | L'Air Liquide, Societé´ Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2026-05-12 | — | — | US | disclosed |
| US-20260116798-A1 | EFFECTIVE TREATMENT OF CHLOROTRIFLUOROETHYLENE (CTFE) OLIGOMERS AND DERIVATIVES | UNIV CALIFORNIA (US) | 2026-04-30 | — | — | US | disclosed |
| EP-0192742-A1 | CYCLIC POLYPEPTIDES HAVING MU-RECEPTOR SPECIFICITY | GIBSON-STEPHENS NEUROPHARMACEUTICALS, INC. (US) | 1986-09-03 | — | — | EP | disclosed |
| WO-1986001516-A1 | CYCLIC POLYPEPTIDES HAVING MU-RECEPTOR SPECIFICITY | GIBSON-STEPHENS NEUROPHARMACEUTICALS, INC. (US) | 1986-03-13 | — | — | WO | disclosed |
| US-4160666-A | Polymeric chemical sensitizers for organic photoconductive compositions | EASTMAN KODAK COMPANY (US) | 1979-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145188-A1 | COMPOSITIONS AND METHODS FOR HYDROCARBON FUNCTIONALIZATION | AHR, HMOX2, ALKBH3 | THRB 2904/4885ACLY 2374/4885TSHR 3870/4885 |
| US-20220185748-A1 | METHODS FOR FUNCTIONALIZATION HYDROCARBONS | AHR, AOX1, HMOX2 | THRB 472/4885ACLY 1428/4885TSHR 442/4885 |
| US-12559448-B2 | Methods for functionalization hydrocarbons | COXFA4, HAO2, PPARG | THRB 20/4885ACLY 1166/4885TSHR 13/4885 |
| US-10450259-B2 | Compositions and methods for hydrocarbon functionalization | AHR, HMOX2, HCCS | THRB 3014/4885ACLY 2027/4885TSHR 3812/4885 |
| US-20170152207-A1 | COMPOSITIONS AND METHODS FOR HYDROCARBON FUNCTIONALIZATION | AHR, HMOX2, ALKBH3 | THRB 2904/4885ACLY 2374/4885TSHR 3870/4885 |
| US-12628589-B2 | Etching method using oxygen-containing hydrofluorocarbon | HAO2, HYOU1, ZYX | THRB 2681/4885ACLY 2600/4885TSHR 1454/4885 |
| US-20260116798-A1 | EFFECTIVE TREATMENT OF CHLOROTRIFLUOROETHYLENE (CTFE) OLIGOMERS AND DERIVATIVES | ALDOA, PFKFB2, MGAM | THRB 1335/4885ACLY 129/4885TSHR 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.